Compare Illumina, Inc. (ILMN) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs J B Hunt Transport Services Inc — how do they compare? Illumina, Inc. trades at $274.64 (market cap $39.95B), while J B Hunt Transport Services Inc trades at $228.28 (market cap $21.45B). The key difference: Illumina, Inc. is the larger of the two by market cap, and J B Hunt Transport Services Inc pays a 0.79% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and J B Hunt Transport Services Inc for 45 Days on average.
| ILMN | JBHT | |
|---|---|---|
Market Cap | $39.95B | $21.45B |
Volume | 3,169,503 | 1,028,680 |
Sector | Health | Industrials |
52-Week High | $293.69 | $298.41 |
52-Week Low | $91.00 | $137.09 |
Typical Hold Time | 83 Days | 45 Days |
Enterprise Value | $41.31B | $22.59B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $271.02, up 1.22% and near its 52-week high, reflecting strong momentum. The stock exhibits a bullish technical trend with recent earnings beats and a positive analyst consensus. Revenue for 2025 was $4.34B with net income of $850M, marking a significant profit margin recovery. Cash flow from operations remains robust at $1.08B, supporting financial stability. Inclusion in the S&P 500 and focus on AI-driven genomics growth are key catalysts.
Outlook is positive given earnings momentum and strategic initiatives, but risks include valuation premiums and competitive pressures. The stock offers growth exposure to genomic innovation, though investors should monitor execution on AI integration and margin sustainability. Analyst price targets suggest moderate upside from current levels, with consensus at $241.00.
JBHT trades at $228.91, up 2.82% today, with a bearish technical signal and neutral oscillators. The company reported revenue of $12.00B in 2025, with net income of $598.28M and a net margin of 5.31%. Recent earnings have consistently beaten estimates, but the stock faces headwinds from rising costs and multiple securities class action investigations announced in late September 2026.
The outlook is mixed: strong analyst consensus with a $289.40 price target suggests upside, but near-term risks from cost pressures and legal scrutiny cloud the picture. Earnings growth and freight demand remain key drivers, yet investor sentiment is cautious amid profit warnings and volatile diesel prices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
